Tirzepatide is an FDA-approved medication for the treatment of obesity. It has proven success for weight management populations with non-syndromic obesity. Special populations such as Prader-Willi Syndrome and Hypothalamic Obesity do not have FDA-approved medications for weight loss. In addition, these special populations have not...
One in five adolescents and young adults with type 1 diabetes exhibit disordered eating behaviors (DEB)—nearly twice the rate among healthy peers and affecting females more than males. Several studies show that those with DEB have worse health outcomes. Researchers at the Seattle Children’s Hospital want...
EVO is a 12-month healthy lifestyle and weight loss research study taking place in the Department of Preventive Medicine at Northwestern University. Researchers are looking to determine the best strategy for weight loss and healthy living. Participants enroll in the 12-month, remotely-delivered study and receive...
